Clinical Trials Logo
  1. Home
  2. Cognitive Symptoms
  3. NCT00134953

Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment

Cognitive Symptoms Clinical Trial

Official title:
Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment

Clinical Trial Summary

This study is designed to investigate the efficacy and safety of rivastigmine compared with placebo in patients with mild cognitive impairment (MCI).

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00134953
Study type Interventional
Source Novartis
Contact
Status Terminated
Phase Phase 3
Start date January 2003
Completion date May 2004
View Details
See also
  Status Clinical Trial Phase
Completed NCT00391378 - Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS) N/A
Completed NCT00387062 - Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment Phase 1
Completed NCT00111267 - Oral Vitamin B12 Supplementation and Cognitive Performance in Elderly People N/A
Completed NCT04813965 - Breast Cancer Patients' Cognitive Symptoms After Information About Chemotherapy-Related Cognitive Symptoms N/A
Active, not recruiting NCT01138020 - Cognitive Rehabilitation of Blast Traumatic Brain Injury (TBI) N/A
Terminated NCT02144688 - COMO: Cognition Study With HIV+ Patients (CTNPT 015) Phase 0
Active, not recruiting NCT00138021 - Cognitive Remediation in Supported Employment at Human Service Center (HSC) N/A
Recruiting NCT01333215 - Study of Cognitive Inhibition Disorders in Depressed Older Suicide Attempters N/A
Completed NCT01578083 - Chemotherapy-Induced Cognitive Impairment N/A